Friday, September 18, 2026
The Cancer News

AN AUTHORITATIVE RESOURCE FOR EVERYTHING ABOUT CANCER

Hyunseok Kang, MD, MPH

Hyunseok Kang, MD, MPH

medical oncologist

Hyunseok Kang, MD, MPH is a medical oncologist at Stanford University specializing in head and neck cancers, including squamous cell carcinoma, salivary gland cancers, thyroid cancers, and other rare tumors. He leads the head and neck cancer research program at the Stanford Cancer Institute and leads head and neck medical oncology at the institution. His research focuses on developing clinical trials of novel therapies, including immunotherapy, targeted agents, and antibody-drug conjugates, to improve outcomes for patients with rare and aggressive head and neck cancers.

Published Articles (1)

Immunotherapy Is Moving Earlier Into Head and Neck Cancer Treatment

September 17, 2026

Head and neck cancer treatment has historically advanced roughly once a decade, but two meaningful updates are arriving together this year